Jordi Rodon logo Vall d’Hebron Institute of Oncology (VHIO) logo

Jordi Rodon

Clinical Head and Co-Director, Research Unit for Molecular Therapy of Cancer; Head, Early Clinical Drug Development Group, Vall d'Hebron Institute of Oncology, VHIO (Spain)


Current Positions:

- Head of the Early Clinical Drug Development Group
- Co-Director of UITM
- Clinical Head of UITM
- Specialist in Medical Oncology and Staff Physician of the Department of Oncology at the Vall d’Hebron University Hospital
- Coordinator of the Brain CNS Tumors Program
- Associate Professor of Oncology at the Universitat Internacional de Catalunya
- Active member of the European Society of Medical Oncology (ESMO), the American Society of Clinical Oncology (ASCO) and the American Association of Cancer Research (AACR)
- Representative of VHIO in the Worldwide Innovative Networking in personalized cancer medicine (WIN) Consortium

Jordi Rodon logo

Jordi Rodon

Clinical Head and Co-Director, Research Unit for Molecular Therapy of Cancer; Head, Early Clinical Drug Development Group, Vall d'Hebron Institute of Oncology, VHIO (Spain)


Vall d’Hebron Institute of Oncology (VHIO) logo

Current Positions:

- Head of the Early Clinical Drug Development Group
- Co-Director of UITM
- Clinical Head of UITM
- Specialist in Medical Oncology and Staff Physician of the Department of Oncology at the Vall d’Hebron University Hospital
- Coordinator of the Brain CNS Tumors Program
- Associate Professor of Oncology at the Universitat Internacional de Catalunya
- Active member of the European Society of Medical Oncology (ESMO), the American Society of Clinical Oncology (ASCO) and the American Association of Cancer Research (AACR)
- Representative of VHIO in the Worldwide Innovative Networking in personalized cancer medicine (WIN) Consortium


Why WIN